Ozkök S - Search Results

1

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A. Yalman D, et al. Among authors: ozkok s. Eur J Gynaecol Oncol. 2003;24(3-4):309-14. Eur J Gynaecol Oncol. 2003. PMID: 12807246

2

Hyperfractionated radiotherapy combined with simultaneous chemotherapy in inoperable non-small cell lung cancer: a pilot study.

Ozkök S, Aras AB, Esassolak MA, Arican AH, Yalman D, Haydaroğlu A. Ozkök S, et al. Monaldi Arch Chest Dis. 1995 Dec;50(6):443-7. Monaldi Arch Chest Dis. 1995. PMID: 8834953

3

Accelerated fractionation (AF) in head and neck cancers.

Esassolak M, Yalman D, Anacak Y, Ozkök S, Haydaroğlu A. Esassolak M, et al. Among authors: ozkok s. Radiother Oncol. 1998 Apr;47(1):103-4. Radiother Oncol. 1998. PMID: 9632302 No abstract available.

4

Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases.

Yalman D, Ozsaran Z, Anacak Y, Celik OK, Ozkök S, Ozsaran A, Hanhan M, Haydaroğlu A. Yalman D, et al. Among authors: ozkok s. Eur J Gynaecol Oncol. 2000;21(3):311-5. Eur J Gynaecol Oncol. 2000. PMID: 10949404

5

High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.

Anacak Y, Mogulkoc N, Ozkok S, Goksel T, Haydaroglu A, Bayindir U. Anacak Y, et al. Among authors: ozkok s. Lung Cancer. 2001 Nov;34(2):253-9. doi: 10.1016/s0169-5002(01)00249-5. Lung Cancer. 2001. PMID: 11679184 Clinical Trial.

6

The impact of the haemoglobin level on the response to radiotherapy.

Haydaroğlu A, Yürüt V, Arican A, Yalman D, Bülent Aras A, Esassolak M, Ozkök S. Haydaroğlu A, et al. Among authors: ozkok s. J BUON. 2002 Jan-Mar;7(1):31-4. J BUON. 2002. PMID: 17577257

7

High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.

Ozkok S, Karakoyun-Celik O, Goksel T, Mogulkoc N, Yalman D, Gok G, Bolukbasi Y. Ozkok S, et al. Lung Cancer. 2008 Dec;62(3):326-33. doi: 10.1016/j.lungcan.2008.03.018. Epub 2008 May 14. Lung Cancer. 2008. PMID: 18482780

8

Postoperative radiotherapy in the management of resected non-small-cell lung carcinoma: 10 years' experience in a single institute.

Karakoyun-Celik O, Yalman D, Bolukbasi Y, Cakan A, Cok G, Ozkok S. Karakoyun-Celik O, et al. Among authors: ozkok s. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):433-9. doi: 10.1016/j.ijrobp.2009.02.010. Epub 2009 Apr 20. Int J Radiat Oncol Biol Phys. 2010. PMID: 19386425

9

Erythropoietin and radiotherapy in lung cancer patients.

Yurut-Caloglu V, Haydaroglu A, Ozkok S, Yalman D, Bolukbasi Y. Yurut-Caloglu V, et al. Among authors: ozkok s. J BUON. 2009 Jul-Sep;14(3):519-21. J BUON. 2009. PMID: 19810149

10

Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.

Ozkok S, Demirci S, Yalman D, Zeytunlu M, Nart D, Yuzer Y, Coker A, Goker E. Ozkok S, et al. Tumori. 2010 Jul-Aug;96(4):560-7. doi: 10.1177/030089161009600408. Tumori. 2010. PMID: 20968135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters